PTTC Network Wide

After attending this webinar from Dr. Sheryl Ryan, viewers should be able to: 1. Describe the biology of cannabis products and the endocannabinoid system. 2. Explain the adverse short and long-term health effects of cannabis products especially during pregnancy and breast-feeding on fetal and neonatal development. 3. Discuss prevention strategies including multi-sector approaches and recommendations for people who are pregnant, planning pregnancy, or breastfeeding. Slide Deck Available: Here

Webinar This webinar occurred on 8/8/23 and a one-hour certificate of attendance is available here If you attended the live event on August 8, 2023. Webinar Resources: Slides. Webinar Presentation: Presentation. Certificate: A one-hour certificate of attendance is available here Summary: The webinar explored Cannabidiol (CBD) products are often marketed for a range of different health conditions; however, there is little evidence to support the safety and effectiveness of over-the-counter, non-FDA-approved CBD products for many of these uses. This webinar will highlight information presented in SAMHSA’s advisory titled, Cannabidiol (CBD) – Potential Harms, Side Effects, and Unknowns, which introduces readers to CBD, how it is derived, and how it differs from other cannabinoids and cannabis products. Participants will learn about the biological and physiological effects of CBD, the risks and harms of CBD use, which include interactions with other drugs and potential risks during pregnancy and fetal development, and common misconceptions about CBD, given its broad availability and marketing for several medical conditions despite limited evidence of efficacy. Panelists: Humberto Carvalho - SAMHSA Substance Abuse & Mental Health Services Administration (SAMHSA) Krishnan Radhakrishnan - SAMHSA National Mental Health and Substance Use Policy Laboratory Substance Abuse & Mental Health Services Administration (SAMHSA) Krishnan Radhakrishnan, MD, PhD, MPH, Physician, Senior Advisor in the National Mental Health and Substance Use Policy Laboratory (NMHSUPL) within the Substance Abuse and Mental Health Services Administration (SAMHSA) is board certified in public health and general preventive medicine. Dr. Radhakrishnan has broad-based research experiences and published extensively in the clinical, epidemiological, biomedical, biological and physical sciences, supported by extensive computational modeling, data analysis, interpretation and synthesis. He received his BSc (Hons) from Imperial College London, MS from Cornell University and Ph.D. from Massachusetts Institute of Technology (MIT), all in Mechanical Engineering. After several years conducting research at NASA’s Glenn Research Center, focusing on mathematical/computational modeling of combustion, with applications in aero and space propulsion, Dr. Radhakrishnan returned to school, earning his M.D. degree from Case Western Reserve University and MPH from University of Kentucky, Lexington, where he received his residency training in general preventive medicine and public health and served as chief resident and American Cancer Society Fellow, focusing on cancer prevention and control. Amy Berninger, MPH - Abt Associates Health Research, Monitoring, and Evaluation Senior Associate Amy Berninger, MPH, has over 12 years of experience working on a variety of projects related to behavioral health policy that have largely focused on research design, implementation, and evaluation in the areas of substance use disorder prevention and treatment. At Abt Associates, she works on both federal and state research projects for the Substance Abuse and Mental Health Services Administration (SAMHSA), Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), Massachusetts Department of Public Health, and others. Through this work, Ms. Berninger has supported institutions with efforts to develop and implement policies and procedures that promote substance use prevention and improve capacity to provide effective treatment and recovery support services for individuals with substance use disorders. Ms. Berninger received her MPH in Epidemiology from Boston University School of Public Health.

  The Technology Transfer Centers: Dissemination and Implementation Working Group, composed of representatives across the ATTC, MHTTC, and PTTC, developed two infographics for the most common intensive technical assistance strategies used to help states, organizations, and front-line providers implement evidence-based services.    The two strategies are: Learning Collaboratives External Facilitation   These are two of many technical assistance strategies offered and deployed across the TTC Network. Additional infographics simply describing other strategies for consumers are in the planning stages. User-friendly infographics are expected to assist decision-makers in making more informed selections about the kinds of assistance or support they need.    Access the infographics by clicking on the Green "Download" button above and selecting between the two options.